Skip to content

A study to understand how homoeopathic treatment can be used to give comfort, relief and better quality of life to patients with advanced cancer, by developing clear guidelines based on real patient cases.

Evolving the parameters for deciding palliative approach with homoeopathy in advance cases of cancer - a case series study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/101782
Enrollment
45
Registered
2026-01-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Dr M L Dhawale Memorial Trust Institute Palghar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All cases above 18 years of age All cases of all types of cancers of advance stage-3rd and 4th identified according to TNM staging. All patients diagnosed with some type of cancer according to histopathological findings. All patients who are being managed according to the conventional management i.e anti-cancer medicines available in form of chemotherapy/surgery/ radiotherapy. All patients who have refused to take conventional treatment or anti-cancer medicines or surgery or radiotherapy. All patients who were refused/advised against taking conventional treatment or anti-cancer medicines or surgery or radiotherapy. All patients who were willing for homoeopathy as an adjuvant to the ongoing treatment or Homoeopathy as a stand alone management for minimum of 1 week to a maximum of 8 weeks. All patient who agree to be observed for a period of 1 week to 8 weeks for this study and who allow their data to be used for this study.

Exclusion criteria

Exclusion criteria: Patients are not willing to undergo homoeopathic treatment. Patients taking treatment for less than 1 week. Incomplete data or assessment between pre and post assessment. Patients not willing to give their data for observation and assessment for this study. Patients with cancer in situ, stage 1 and stage 2. All patient who require immediate emergency management in form of life support- ventilators etc.

Design outcomes

Primary

MeasureTime frame
To evolve the parameters for deciding the palliative approach in advanced cases of cancer.Timepoint: 8 weeks

Secondary

MeasureTime frame
noneTimepoint: none

Countries

India

Contacts

Public ContactDr Mehvish Haris Dandoti

Dr M L Dhawale Memorial Trust Institute

mehvish0027@gmail.com7738403423

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026